STOCK TITAN

Impact Biomedical Stock Price, News & Analysis

IBO NYSE

Company Description

Company Overview

Impact BioMedical Inc. (IBO) is a pioneering biotechnology company that is reshaping the landscape of drug discovery and consumer healthcare by combining advanced scientific research with innovative technology platforms. The company focuses on the development and patenting of unique scientific solutions that target neurological, oncological, and immune-related diseases while also creating advanced technologies designed for everyday wellness, including natural insect repellents and cutting‐edge air purification systems.

Core Business and Technology Platforms

At its core, Impact BioMedical is committed to addressing unmet needs in human health. The company employs a multifaceted approach to biopharmaceutical innovation through its proprietary platforms such as 3F™ and Linebacker™. The 3F™ technology involves the generation of natural compositions obtained from plant-based constituents and fragrances, which are formulated as insect repellents to reduce contact with disease-bearing insects. Meanwhile, the Linebacker™ platform focuses on developing small molecule compounds with electrophilically enhanced phenolic properties, offering potential applications in the treatment of inflammatory disorders, oncology, and neurology.

Innovative Patent Portfolio

One of the company’s defining features is its robust and diverse patent portfolio. Impact BioMedical has secured multiple patents that solidify its technological edge in both biopharmaceutical and consumer healthcare arenas. Notable patents protect unique compositions and formulations for natural insect repellents, as well as innovative therapeutic agents aimed at modulating inflammatory responses. These patents not only create barriers to entry for competitors but also serve as the foundation for potential licensing and co-development opportunities with strategic partners.

Business Model and Collaborative Partnerships

The company operates through a collaborative business model, working closely with external partners via licensing agreements, co-development initiatives, and joint ventures. This approach allows Impact BioMedical to leverage external expertise while focusing on core research and intellectual property development. By aligning with industry partners, the company is able to accelerate the advancement of its patented technologies into the market, ensuring a diversified revenue stream that includes milestone payments, royalty revenues, and shared development efforts.

Diversification in Product Categories

Impact BioMedical’s product pipeline is broadened by its strategic acquisitions and new technology initiatives. For instance, the recent acquisition of Celios® introduces advanced air purification technology into its portfolio. Celios® features patented designs and systems that achieve near clean-room air quality through innovative filtration, thereby complementing the company’s existing technologies. This acquisition demonstrates Impact BioMedical's commitment to integrating diverse technologies into a comprehensive suite of health and wellness solutions aimed at improving quality of life.

Competitive Position and Market Significance

By combining rigorous scientific research with a strong patent estate, Impact BioMedical differentiates itself in the competitive biotechnology and healthcare innovation market. Its strength lies in its focused research on natural compounds and proprietary formulations that support both therapeutic and consumer product applications. The company’s strategic partnerships and licensing models further enhance its ability to monetize advanced discoveries while mitigating risks typically associated with early-stage pharmaceutical development. This innovative multi-pronged strategy not only reinforces its position in traditional biopharmaceutical sectors but also opens new avenues in consumer wellness markets.

Research and Development Excellence

Impact BioMedical has built a reputation for excellence in research and development, driven by deep scientific understanding and robust technological platforms. The company’s efforts in translating innovative science into viable commercial applications are reflected in its diverse patent portfolio and ongoing collaborations with other industry innovators. By maintaining a disciplined focus on the discovery and confirmation of unique science, the company consistently brings forward products that are backed by extensive pre-clinical research and intellectual property protection.

Operational and Strategic Focus

The operational strategy of Impact BioMedical emphasizes sustainable growth through balanced investments in research, development, and strategic collaborations. By harnessing advanced scientific expertise and fostering relationships with partners in research, licensing, and joint ventures, the company supports its mission to deliver cutting-edge healthcare and wellness solutions. The comprehensive approach includes regular advancements in technology platforms and an agile business structure that is adaptable to evolving market needs.

Conclusion

In summary, Impact BioMedical Inc. stands out due to its integrated strategy that combines robust patent protection, diversified technology platforms, and collaborative business approaches. The company’s focus on both therapeutic and consumer healthcare applications positions it uniquely within the biotechnology industry. As it continues to leverage advanced discovery techniques and strategic partnerships, Impact BioMedical remains a significant entity in the exploration and commercialization of next-generation health and wellness solutions.

Additional Insights

  • Scientific Rigor: Every innovation is backed by detailed research and confirmed through stringent patenting processes.
  • Innovation in Action: Platforms like 3F™ and Linebacker™ exemplify the company’s ability to harness natural compounds for improved human health.
  • Strategic Partnerships: Joint ventures and licensing collaborations allow for shared expertise and accelerated market entry.
  • Diversified Revenue Streams: Beyond traditional drug discovery, the company also taps into consumer healthcare through technologies that address everyday challenges.

This comprehensive overview offers a detailed understanding of Impact BioMedical Inc.’s operations, technological innovations, and market approach, making it a crucial study subject for stakeholders interested in the convergence of biotechnology and consumer wellness solutions.

Stock Performance

$0.4250
0.00%
0.00
Last updated: April 25, 2025 at 05:30
-45.9 %
Performance 1 year
$5.3M
Market Cap
12.1M
Shares outstanding

SEC Filings

No SEC filings available for Impact Biomedical.

Financial Highlights

$0
Revenue (TTM)
-$24,770,000
Net Income (TTM)
-$2.30
Diluted EPS (TTM)
-$3,919,000
Operating Cash Flow
0.25
Current Ratio
-$28,753,000
Operating Income

Upcoming Events

Frequently Asked Questions

What is the current stock price of Impact Biomedical (IBO)?

The current stock price of Impact Biomedical (IBO) is $0.425 as of April 24, 2025.

What is the market cap of Impact Biomedical (IBO)?

The market cap of Impact Biomedical (IBO) is approximately 5.3M.

What is the revenue (TTM) of Impact Biomedical (IBO) stock?

The trailing twelve months (TTM) revenue of Impact Biomedical (IBO) is $0.

What is the net income of Impact Biomedical (IBO)?

The trailing twelve months (TTM) net income of Impact Biomedical (IBO) is -$24,770,000.

What is the earnings per share (EPS) of Impact Biomedical (IBO)?

The diluted earnings per share (EPS) of Impact Biomedical (IBO) is -$2.30 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Impact Biomedical (IBO)?

The operating cash flow of Impact Biomedical (IBO) is -$3,919,000.

What is the current ratio of Impact Biomedical (IBO)?

The current ratio of Impact Biomedical (IBO) is 0.25, indicating the company's ability to pay short-term obligations.

What is the operating income of Impact Biomedical (IBO)?

The operating income of Impact Biomedical (IBO) is -$28,753,000.

What is Impact BioMedical Inc.'s core business?

Impact BioMedical Inc. is dedicated to advancing drug discovery and developing innovative healthcare solutions, focusing on neurological, oncological, and immune-related diseases, as well as consumer wellness applications.

How does Impact BioMedical generate revenue?

The company generates revenue through collaborative partnerships, licensing deals, co-development projects, and joint ventures that help commercialize its patented technologies and innovative solutions.

What are the key technology platforms utilized by Impact BioMedical?

Impact BioMedical employs proprietary platforms like 3F™ and Linebacker™. The 3F™ platform focuses on natural compositions for insect repellent applications, while the Linebacker™ platform develops small molecule compounds for treating inflammatory and oncological conditions.

Which market segments does Impact BioMedical serve?

The company serves diverse market segments including biopharmaceutical research, therapeutic drug development, and consumer healthcare, with products aimed at addressing neurological, oncological, and immune disorders.

How does the company protect its innovations?

Impact BioMedical has built a strong patent portfolio that includes multiple issued patents for its unique formulations and technologies, providing a competitive edge and safeguarding its innovations in both therapeutic and consumer applications.

What role do strategic partnerships play in the business model?

Strategic partnerships are central to Impact BioMedical’s business model, allowing the company to tap into external expertise, share development risks, and accelerate the commercialization of its technologies through licensing and co-development agreements.

What is the significance of the Celios® acquisition?

The acquisition of Celios® adds advanced air purification technology to Impact BioMedical’s portfolio, enhancing its offering in consumer healthcare solutions and reinforcing its strategic commitment to integrated technological innovation.

How does Impact BioMedical differentiate itself from competitors?

The company differentiates itself through its unique combination of advanced patent-protected technology platforms, a diversified product pipeline, and a collaborative business model that leverages partnerships to drive innovation in both biopharmaceutical and consumer wellness markets.